Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
The Journal of Clinical Investigation|August 3, 2016
The impact of hypoxia on tumor-associated macrophagesAnne-Theres Henze, Massimiliano MazzoneCell Cycle (Georgetown, Tex.)|July 7, 2010
Feedback regulators of hypoxia-inducible factors and their role in cancer biologyAnne-Theres Henze, Till AckerFASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 4, 2015
Factor-inhibiting HIF-1 (FIH-1) is required for human vascular endothelial cell survivalSerafim Kiriakidis, Anne-Theres Henze, Ilona Kruszynska-Ziaja, et al.Cancer Research|December 24, 2009
Prolyl hydroxylases 2 and 3 act in gliomas as protective negative feedback regulators of hypoxia-inducible factorsAnne-Theres Henze, Johanna Riedel, Tanja Diem, et al.Cancer Research|January 18, 2018
PHD3 Controls Lung Cancer Metastasis and Resistance to EGFR Inhibitors through TGFαHiginio Dopeso, Hui-Ke Jiao, Angel M Cuesta, et al.Nature Communications|November 26, 2014
PHD3 regulates EGFR internalization and signalling in tumoursBoyan K Garvalov, Franziska Foss, Anne-Theres Henze, et al.Brain : a Journal of Neurology|April 9, 2010
A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2 alphaSascha Seidel, Boyan K Garvalov, Valtteri Wirta, et al.EMBO Molecular Medicine|April 26, 2013
PHD2 regulates arteriogenic macrophages through TIE2 signallingAlexander Hamm, Lorenzo Veschini, Yukiji Takeda, et al.Nature Communications|November 26, 2014
Loss of PHD3 allows tumours to overcome hypoxic growth inhibition and sustain proliferation through EGFRAnne-Theres Henze, Boyan K Garvalov, Sascha Seidel, et al.Cancer Cell|August 18, 2012
Gene-targeting of Phd2 improves tumor response to chemotherapy and prevents side-toxicityRodrigo Leite de Oliveira, Sofie Deschoemaeker, Anne-Theres Henze, et al.Pageof 2